Press Release June 10

Home

Consulting Services

Capabilities

News

Clients

Partners and Alliances

White Papers

Contact Information

The Big Picture

Press Release June 10, 2003

RCN & Vigilex announce a strategic partnership to provide global pharmacovigilance consultancy.

RCN Associates, Inc., of Annapolis, Maryland USA, and Vigilex BV of Rotterdam, The Netherlands are pleased to announce their new Strategic Partnership. Effective immediately, RCN and Vigilex will coordinate their complementary skills and resources in order to provide world-class drug safety consultation and services for global pharmaceutical companies.

RCN brings to the partnership a wide range of expertise, principally within the USA, focused on drug safety, epidemiology, U.S. regulatory affairs, and IT systems design.

Vigilex brings a similarly wide range of expertise in vigilance for both pharmaceutical and medical device companies, adverse event/incident management, periodic reporting, auditing and training, with a major focus on Europe.

RCN & Vigilex’ complementary skills and capabilities will enable the new partnership to provide drug safety consultation and services of the highest quality to international pharmaceutical companies.

About Vigilex BV

Vigilex is Europe’s first Contract Safety Surveillance Organisation (CSO) with a unique team of enthusiastic, qualified staff with an excellent combination of knowledge and experience in (pharmaco) vigilance.

Vigilex’s activities cover the whole range of pre- and post-authorisation for prescription and OTC (human & veterinary) drugs as well as vigilance for Medical Devices. Vigilex can act therefore as a partner throughout the whole lifecycle of a product. Clients include both small and large organisations with European, Japanese and American headquarters. With a presence in a number of European countries, Vigilex offers a cost-effective solution to the requirement or request for a local drug safety officer in the period after marketing approval.

Vigilex has extensive experience in the auditing of pharmacovigilance and related departments.

About RCN Associates, Inc.

RCN Associates, Inc. was formed in 1998 to promote the science of prescription drug safety. It is headquartered where the Severn River meets the Chesapeake Bay in Annapolis, Maryland, USA.

RCN Associates, Inc. believes that therapeutic drug risk management involves the ability to detect and measure safety outcomes, and to communicate that risk in a timely manner. This requires enhanced sources of dedicated drug safety data from clinical practice environments along with product labelling that quickly and accurately communicates that new information.

RCN Associates, Inc. believes that therapeutic risk management needs to be driven by rigorous science and best practices. Those best practices are most efficient and effective if enabled by validated technology.

Both RCN Associates, Inc. and Vigilex use a wide network of experts, alliances and partnerships to support the needs of its clients.

Vigilex BV
Oudedijk 9^B,

3062 AB Rotterdam, The Netherlands

Telephone: +31-(0)10-244 73 99

Fax +31-(0)10-244 73 19

Email: mail@vigilex.com

Internet: www.vigilex.com

CEO: Dr. Maria Koster, Ph.D

For contacts persons in the affiliates: www.vigilex.com

RCN Associates, Inc.

36 East Lake Drive

Suite 200